In the fiercely competitive inflammatory bowel disease (IBD) market, Eli Lilly is making the case for its antibody Omvoh as a ...

U.S.-based generic drugmaker Par Health has issued a voluntary recall of 22 lots of the direct thrombin inhibitor argatroban ...

As the momentum continues to pick up at NorthStar Medical Technologies, the radioisotope producer is strengthening ties in ...

Compass Pathways has partnered with mental health organizations on the first-ever awareness day for treatment-resistant ...

Meridian Medical Technologies—the global health security subsidiary of CDMO Kindeva—just secured a major contract, worth up to a potential $226 million, with the DoD's Defense Logistics Agency to ...

Hot off a pair of key FDA green lights this summer, rare disease specialist Ultragenyx has wasted little time cashing in a ...

Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into ...

With a yearslong patent dispute between the two drugmakers finally put to bed—complete with a hefty settlement payout—United ...

Expanding its presence in dermatology, Cetaphil maker Galderma has agreed to acquire professional skincare shop Zo Skin ...

Seizing that momentum these past two weeks were Prolific Machines—aiming optogenetics at current biomanufacturing ...

The U.S. Court of Appeals for the Third Circuit has rejected an IRA price negotiation lawsuit from Novartis, seven days after doing the same on an appeal from Bristol Myers Squibb and Johnson & ...

Sanofi has avoided a European Union fine after antitrust regulators accepted its commitments to address the alleged ...